These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 17067523)

  • 1. [Pharmacokinetics of alpha1-antitrypsin replacement therapy in severe congenital emphysema].
    Vidal Pla R; Padullés Zamora N; Sala Piñol F; Jardí Margaleff R; Rodríguez Frías F; Montoro Ronsano JB
    Arch Bronconeumol; 2006 Oct; 42(10):553-6. PubMed ID: 17067523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous human plasma-derived augmentation therapy in alpha 1-antitrypsin deficiency: from pharmacokinetic analysis to individualizing therapy.
    Zamora NP; Pla RV; Del Rio PG; Margaleff RJ; Frias FR; Ronsano JB
    Ann Pharmacother; 2008 May; 42(5):640-6. PubMed ID: 18413692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-1 antitrypsin Null mutations and severity of emphysema.
    Fregonese L; Stolk J; Frants RR; Veldhuisen B
    Respir Med; 2008 Jun; 102(6):876-84. PubMed ID: 18353624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmentation therapy for emphysema due to alpha-1-antitrypsin deficiency.
    Tirado-Conde G; Lara B; Miravitlles M
    Ther Adv Respir Dis; 2008 Feb; 2(1):13-21. PubMed ID: 19124355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-1-antitrypsin and other proteinase inhibitors.
    Miravitlles M
    Curr Opin Pharmacol; 2012 Jun; 12(3):309-14. PubMed ID: 22365503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-1-antitrypsin deficiency: optimal therapeutic regimen based on population pharmacokinetics.
    Soy D; de la Roza C; Lara B; Esquinas C; Torres A; Miravitlles M
    Thorax; 2006 Dec; 61(12):1059-64. PubMed ID: 16928711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmentation therapy in alpha-1 antitrypsin deficiency: advances and controversies.
    Tonelli AR; Brantly ML
    Ther Adv Respir Dis; 2010 Oct; 4(5):289-312. PubMed ID: 20650978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aralast: a new alpha1-protease inhibitor for treatment of alpha-antitrypsin deficiency.
    Louie SG; Sclar DA; Gill MA
    Ann Pharmacother; 2005 Nov; 39(11):1861-9. PubMed ID: 16219903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of α1-antitrypsin deficiency.
    Stoller JK; Aboussouan LS
    Am J Respir Crit Care Med; 2012 Feb; 185(3):246-59. PubMed ID: 21960536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-1 antitrypsin (AAT) deficiency - what are the treatment options?
    Modrykamien A; Stoller JK
    Expert Opin Pharmacother; 2009 Nov; 10(16):2653-61. PubMed ID: 19827990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of alpha-1 antitrypsin deficiency.
    Ranes J; Stoller JK
    Semin Respir Crit Care Med; 2005 Apr; 26(2):154-66. PubMed ID: 16088434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma levels of alpha1-antichymotrypsin and secretory leukocyte proteinase inhibitor in healthy and chronic obstructive pulmonary disease (COPD) subjects with and without severe alpha1-antitrypsin deficiency.
    Hollander C; Westin U; Wallmark A; Piitulainen E; Sveger T; Janciauskiene SM
    BMC Pulm Med; 2007 Jan; 7():1. PubMed ID: 17261175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for alpha1-antitrypsin deficiency in Lithuanian patients with COPD.
    Sitkauskiene B; Serapinas D; Blanco I; Fernández-Bustillo E; Janciauskiene S; Sakalauskas R
    Respir Med; 2008 Nov; 102(11):1654-8. PubMed ID: 18722101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung volume reduction surgery in patients with emphysema and alpha-1 antitrypsin deficiency.
    Stoller JK; Gildea TR; Ries AL; Meli YM; Karafa MT;
    Ann Thorac Surg; 2007 Jan; 83(1):241-51. PubMed ID: 17184672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tailored pharmacokinetic dosing allows self-administration and reduces the cost of IV augmentation therapy with human alpha(1)-antitrypsin.
    Piitulainen E; Bernspång E; Björkman S; Berntorp E
    Eur J Clin Pharmacol; 2003 Jun; 59(2):151-6. PubMed ID: 12728289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha1-antitrypsin replacement therapy controls fibromyalgia symptoms in 2 patients with PI ZZ alpha1-antitrypsin deficiency.
    Blanco I; Canto H; de Serres FJ; Fernandez-Bustillo E; Rodríguez MC
    J Rheumatol; 2004 Oct; 31(10):2082-5. PubMed ID: 15468381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic flow chart for targeted detection of alpha1-antitrypsin deficiency.
    Corda L; Bertella E; Pini L; Pezzini A; Medicina D; Boni E; Guerini M; Trivella S; Grassi V; Tantucci C
    Respir Med; 2006 Mar; 100(3):463-70. PubMed ID: 16043335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.
    Likar R; Lorenz V; Korak-Leiter M; Kager I; Sittl R
    Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term supplementation therapy does not affect elastin degradation in severe alpha(1)-antitrypsin deficiency. The American-Italian AATD Study Group.
    Gottlieb DJ; Luisetti M; Stone PJ; Allegra L; Cantey-Kiser JM; Grassi C; Snider GL
    Am J Respir Crit Care Med; 2000 Dec; 162(6):2069-72. PubMed ID: 11112116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and safety of intravenously administered citrulline in children undergoing congenital heart surgery: potential therapy for postoperative pulmonary hypertension.
    Barr FE; Tirona RG; Taylor MB; Rice G; Arnold J; Cunningham G; Smith HA; Campbell A; Canter JA; Christian KG; Drinkwater DC; Scholl F; Kavanaugh-McHugh A; Summar ML
    J Thorac Cardiovasc Surg; 2007 Aug; 134(2):319-26. PubMed ID: 17662768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.